百济神州、科伦博泰等8家药企大单品剖析

制药网
23 Jul

【制药网 市场分析】在全球医药市场的激烈竞争中,各大药企纷纷凭借自身的研发实力和市场策略,推出了一系列具有影响力的大单品。以下将对百济神州、科伦博泰生物、康方生物、三生制药、百利天恒、信达生物、石药集团、一品红等企业的全球大单品进行深入剖析。​百济神州:百悦泽与百泽安双轮驱动​百济神州作为全球肿瘤治疗创新公司,其核心产品百悦泽(泽布替尼)和百泽安(替雷利珠单抗)在全球市场表现亮眼。​百悦泽(泽布...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10